These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32441632)

  • 1. Increased Community-Associated Clostridioides difficile Infections in Quebec, Canada, 2008-2015
    Zanichelli V; Garenc C; Villeneuve J; Moisan D; Frenette C; Loo V; Longtin Y;
    Emerg Infect Dis; 2020 Jun; 26(6):1291-1294. PubMed ID: 32441632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015-2020.
    Silva A; Du T; Choi KB; Pelude L; Golding GR; Hizon R; Lee BE; Chow B; Srigley JA; Hota SS; Comeau JL; Thampi N;
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):222-225. PubMed ID: 36718660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.
    Al-Tawfiq JA; Rabaan AA; Bazzi AM; Raza S; Noureen M
    Am J Infect Control; 2020 Oct; 48(10):1152-1157. PubMed ID: 32122671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of high-risk antibiotic use in incidence of health-care-associated Clostridioides difficile infection in Quebec, Canada: a population-level ecological study.
    Fortin E; Thirion DJG; Ouakki M; Garenc C; Lalancette C; Bergeron L; Moisan D; Villeneuve J; Longtin Y;
    Lancet Microbe; 2021 May; 2(5):e182-e190. PubMed ID: 35544207
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Younas M; Royer J; Weissman SB; Winders HR; Dash S; Bookstaver PB; Justo JA; Waites KS; Bell L; Al-Hasan MN
    Infect Control Hosp Epidemiol; 2021 May; 42(5):622-624. PubMed ID: 33239121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for Asymptomatic Household Transmission of Clostridioides difficile Infection Associated with Recently Hospitalized Family Members.
    Miller AC; Arakkal AT; Sewell DK; Segre AM; Pemmaraju SV; Polgreen PM;
    Emerg Infect Dis; 2022 May; 28(5):932-939. PubMed ID: 35447064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and Preventive Strategies for Clostridioides difficile Transmission to Household or Community Contacts during Transition in Healthcare Settings.
    Asgary R; Snead JA; Wahid NA; Ro V; Halim M; Stribling JC
    Emerg Infect Dis; 2021 Jul; 27(7):1776-1782. PubMed ID: 34152967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008-2013.
    Kotila SM; Mentula S; Ollgren J; Virolainen-Julkunen A; Lyytikäinen O
    Emerg Infect Dis; 2016 Oct; 22(10):1747-1753. PubMed ID: 27648884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained reductions in unnecessary antimicrobial administration and hospital
    Gaffin N; Spellberg B
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):491-493. PubMed ID: 34915961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs Associated with the Treatment of Clostridioides Difficile Infections.
    Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridioides difficile infection in US hospitals: a national inpatient sample study.
    Ramai D; Dang-Ho KP; Lewis C; Fields PJ; Ofosu A; Barakat M; Aamar A; Ofori E; Lai J; Lanke G; Dhaliwal A; Reddy M; Gasperino J
    Int J Colorectal Dis; 2020 Oct; 35(10):1929-1935. PubMed ID: 32556651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteremia due to a toxin A-negative, B-positive Clostridioides difficile ribotype 017 strain.
    Kachrimanidou M; Protonotariou E; Kaiafa G; Ζtrieva E; Skoura L; Savopoulos C; Kuijper E
    Anaerobe; 2020 Jun; 63():102195. PubMed ID: 32234350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.
    Bertolino L; Patauner F; Gagliardi M; D'Amico F; Crivaro V; Bernardo M; Scherillo I; Bellitti F; Cusano C; Greco R; Panetta V; Durante A; Di Caterino A; Frieri A; Cioffi G; Nappo M; Corrado M; Lanzieri M; Sabatini P; Bettelli R; Dello Russo R; Taddeo ML; Petrone R; Di Sevo MG; Iannuzzo M; Iervolino M; Buonocore R; D'Agostino F; Gambardella M; De Martino A; Spagnuolo S; Savarese M; Sole S; Russo C; Agozzino E; Galdiero M; Martino R; Calemma R; Sciambra A; Aprea C; Colaccio D; Di Guida P; Venditti M; Montella E; Guerriero F; Perrotta R; Di Filippo U; Pizza A; Di Fronzo A; Lombardi A; Capuano L; De Stefano A; Mastropietro A; Mastro M; Loffreda R; Maccarone L; Di Tora A; Oto S; Tammaro C; Mondelli AC; Ruocco M; Ferraro B; Petrosino A; Presta SSA; Durante Mangoni E
    Infez Med; 2021 Mar; 29(1):70-78. PubMed ID: 33664175
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Righolt CH; Zhang G; Hammond GW; Lagace-Wiens P; Mahmud SM
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1212-1214. PubMed ID: 32624038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends and predictors of laboratory-confirmed recurrent and severe
    Shaffer SR; Nugent Z; Walkty A; Yu BN; Lix LM; Targownik LE; Bernstein CN; Singh H
    CMAJ Open; 2020; 8(4):E737-E746. PubMed ID: 33199507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study.
    Younas M; Royer J; Weissman SB; Waites KS; Dash S; Rac H; Bookstaver PB; Justo JA; Bell L; Maki A; Al-Hasan MN
    Infection; 2020 Feb; 48(1):129-132. PubMed ID: 31677084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to prevent adverse outcomes following
    Rauseo AM; Olsen MA; Reske KA; Dubberke ER
    Expert Rev Anti Infect Ther; 2020 Mar; 18(3):203-217. PubMed ID: 31976779
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of laboratory-identified event surveillance to classify adverse outcomes due to
    Shen Y; Ellison J; Leal J; Bush KR; Chandran AU; Fathima S; Conly JM
    Infect Control Hosp Epidemiol; 2021 May; 42(5):557-564. PubMed ID: 33222722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.